ConductScience.org, home

Gene · 4860

Papers3,553

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Pathway and Mechanism for the Biodegradation of Inosine and Guanosine by Heyndrickxia coagulans NJ01.Foods202642794039PubTator, text miningPubMed
Integrated transcriptomics and metabolomics reveal suppression of the PPAR α/γ pathway linking purine metabolism disorder to high-protein diet-induced hyperuricemia in goslings.Anim Nutr202642741484PubTator, text miningPubMed
Exploring Novel Indazole and Pyrazole Nucleoside Analogues: Enzymatic Synthesis, Characterization, and Biological Evaluation.Int J Mol Sci202642737455PubTator, text miningPubMed
Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunities.RSC Med Chem202642689267PubTator, text miningPubMed
Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults.J Alzheimers Dis202642669799PubTator, text miningPubMed
Cadmium-associated cognitive impairment in adults: Proteomics-guided blood-based risk stratification with external validation and rat multimodal corroboration.Environ Pollut202642641860PubTator, text miningPubMed
Extending Chain Length of PNP Pincer Ligands Triggers Catalytic Activity of Gold-Copper Nanoclusters in Aerobic Oxidations.Angew Chem Int Ed Engl202642585034PubTator, text miningPubMed
Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations.Biochem Biophys Res Commun202642580172PubTator, text miningPubMed
Proton motive force as a driver of persister sensitization by adenosine.J Biol Chem202642567508PubTator, text miningPubMed
Comprehensive analysis of the association between perfluorooctanoic acid exposure and osteosarcoma progression.Food Chem Toxicol202642462996PubTator, text miningPubMed
Barbaloin Alleviates Lung Ischemia-Reperfusion Injury by Dual-Targeting IL-6 and PNP.Int J Mol Sci202642352997PubTator, text miningPubMed
A plug-and-play method for guided multi-contrast MRI reconstruction based on content/style modeling.Med Image Anal202642330835PubTator, text miningPubMed
Rationale for the Use of 8-Aminoguanine for the Management of Cystitis.Int J Urol202642303425PubTator, text miningPubMed
Multi-omics profiling identifies inosine as a key metabolite associated with embryonic arrest in hydrosalpinx-associated infertility.EBioMedicine202642167122PubTator, text miningPubMed
Base editing and nanoparticle transfection of airway cell types essential for treatment of cystic fibrosis.JCI Insight202642100873PubTator, text miningPubMed
Pneumococcal Serological Evaluation in Vaccinated Children Diagnosed with Transient Hypogammaglobulinemia of Infancy and Unclassified Hypogammaglobulinemia.Int Arch Allergy Immunol202642096373PubTator, text miningPubMed
SCID newborn screening: seven-year performance and outcomes including T-cell lymphopenia in Catalonia (Spain).Front Immunol202642079620PubTator, text miningPubMed
Network toxicology and single-cell transcriptomics nominate candidate pyrethroid-associated targets and pathways in clear cell renal cell carcinoma.Naunyn Schmiedebergs Arch Pharmacol202641949597PubTator, text miningPubMed
Sequenced Care Pathway vs Pain Navigator Pathway for Veterans With Low Back Pain: The AIM-Back Cluster Randomized Clinical Trial.JAMA Netw Open202641926124PubTator, text miningPubMed
Green-Synthesized Nanomaterials for Catalytic Reduction of para-Nitrophenol and Methylene Blue: Recent Advances and Perspectives.Nanomaterials (Basel)202641893237PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4860/papers